Clinical development of liposomal platinum

Roman Perez Soler, A. R. Khokhar, Julio Lautersztain, Salam Al Baker, Karen Francis, Dede Macias Kiger, G. Lopez Berestein

Research output: Contribution to journalArticle

8 Scopus citations


We have been interested for several years in the development of carrier-dependent antitumor agents. these agents should have the following properties: enhanced antitumor activity compared with the parent compound, decreased toxicity, lack of cross-resistance, and compatibility with the drug carrier.

Original languageEnglish (US)
Pages (from-to)437-449
Number of pages13
JournalJournal of Liposome Research
Issue number4
StatePublished - Jan 1 1990
Externally publishedYes

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Clinical development of liposomal platinum'. Together they form a unique fingerprint.

  • Cite this

    Soler, R. P., Khokhar, A. R., Lautersztain, J., Baker, S. A., Francis, K., Kiger, D. M., & Berestein, G. L. (1990). Clinical development of liposomal platinum. Journal of Liposome Research, 1(4), 437-449.